The political dimension of blood and plasma derivatives

Pharmaceuticals Policy and Law

Volumn 7, Issue , 2005, Pages 21-23

  Valverde, José Luís ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870563773     PISSN: 13892827     EISSN: 2210495X     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. N. Dhingra, Lloyd, Fordham, Amin, Challenges in global blood safety, Transfuse Med 14(2) (2004), 105-112.
2. N. Dhingra-Kumar, Overview of the global situation in blood safety, Report of the first meeting of the Global Collaboration for Blood Safety. WHO. 2000.
3. Anonymous, The Right to Healthcare, Multinational Monitor 25(10) (2004), 5.
4. J. Hoey, Human rights, ethics and the Krever inquiry, Canadian Medical Association, Journal 157(9) (1997), 1231.
5. E. Tabor, The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1, Transfusion 39 (1999), 11-12.
6. Fischer, Andrea, the then German Health Minister, quoted on World Health Day, 7 April 2000.
7. L. Mascaretti, James, Barbara, Cardenas, Blagoevska, Haracic, Rossi, Comparative analysis of national regulations concerning blood safety across Europe, Transfus Apheresis Sci 31(2) (2004), 99-110.
8. K. McCurdy and J. Otter, Regulatory and legislative issues in transfusion medicine, Clin Lab Med 12(4) (1992), 835-844.
9. M. Gustafson, Blood safety. The Food and Drug Administration’s role, Arch Pathol Lab Med 123(6) (1999), 475-477.
10. Commission of inquiry on the blood system in Canada: final report. Canadian Government Publishing. PWGSC. 1997. The chapter Some Important Milestones: HIV and AIDS, 1981-1994, constitutes the most serious document published by establishing the timescales of recognizing the signs and transmission HIV and AIDS. The same can be said of the chapter dedicated to Some Important Milestones: Hepatitis, 1965-1995.
11. N. Boyce, C. Brook and T. Better, Safer Blood Transfusion, A report for the Australian Council for safety and quality in health Care. 28th October 2004.
12. Council Recommendation 98/463/EEC of June 1998 on the Suitability of Blood and Plasma Donors and the Screening of Donated Blood in the European Community. European Union.
13. Directive 2002/98/ EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC. 8.2.2003 L 33/30 Official Journal of the European Union.
14. CPMP Position Statement: Non-remunerated donors: safety & supply of plasma-derived medicinal products (EMEA/CPMP/BWP/1818/02/Final).
15. F.M. Delaney, The collection and use of human blood and plasma in the European Community in 1993, Brussels: European Commission, 1995. (CEC/Lux/V/F/1/33.)
16. A. Farrugia, Regulatory challenges to global harmonization and expanded access to concentrates: how will regulators balance the increasing cost of new safety requirements with the desire to increase the availability of affordable product? Clin Lab Med 12(4) (1992), 835-844.
17. H.W. Reesink and P.E. Strengers, Worldwide perspective in transfusion safety: Europe, Dev Biol 102 (2000), 205-210. Review.
18. C.T. Smit Sibinga, R.isk management: an important tool for improving quality, Transfus Clin Biol 8(3) (2001), 214-217.
19. B. McClelland, E. Love, S. Scott and L.M.Williamson, Haemovigilance: concept, Europe and UK initiatives, Vox Sang 74(2) (1998), 431-439.
20. J.C. Faber, Worldwide overview of existing haemovigilance systems, Transfus Apheresis Sci 31(2) (2004), 95-98.
21. C.P. Engelfriet, H.W. Reesink, B. Brand, G. Levy, L.M. Williamson, J.E. Menitove, H.E. Heier, J. Jorgensen, C. Politis, H. Seyfried, C.T. Smit Sibinga, J.C. Faber, M.A. Vesga, E. Selivanov, T. Danilova, K. Tadokoro, T. Krusius, V. Hafner, I. Snopek, G. Reali and J. d’Almeida Goncalves, Haemovigilance systems. Vox Sang. 77(2) (1999), 110-120.
22. J.E. Menitove, Hemovigilance in the United States of America, Vox Sang 74(2) (1998), 447-455.
23. M. Busch, M. Chamberland, J. Epstein, S. Kleinman, R. Khabbaz and G. Nemo, Oversight and Monitoring of Blood Safety in the United States, Vox Sanguinis 77 (1999), 67-76.
24. Report of the first meeting of the Global Collaboration for Blood Safety. WHO. Geneva, 14-17 November 200. http://www.who.int/bct/Main areas of work/BTS/GCBS/Publications/ GCBS1 Report.doc.
25. http://www.wto.org/.